| KDP | Name: | 2-KETO-DEOXY-GALACTOSE | Formula: | C6 H11 O9 P | SMILES: | O=P(O)(O)OCC(O)C(O)CC(=O)C(=O)O | InChi: | InChI=1S/C6H11O9P/c7-3(1-4(8)6(10)11)5(9)2-15-16(12,13)14/h3,5,7,9H,1-2H2,(H,10,11)(H2,12,13,14)/t3-,5-/m1/s1 | Definition date: | 2007-08-02 | Last modified: | 2024-09-27 | Identifier: | 3-deoxy-6-O-phosphono-D-threo-hex-2-ulosonic acid |
|
| J5D | Name: | N-[(4-fluoro-3-methylphenyl)methyl]acetamide | Formula: | C10 H12 F N O | SMILES: | CC(=O)NCc1cc(c(cc1)F)C | InChi: | InChI=1S/C10H12FNO/c1-7-5-9(3-4-10(7)11)6-12-8(2)13/h3-5H,6H2,1-2H3,(H,12,13) | Definition date: | 2018-08-13 | Last modified: | 2024-09-27 | Release date: | 2019-12-18 | Identifier: | N-[(4-fluoro-3-methylphenyl)methyl]acetamide |
|
| J5G | Name: | N-(5-methyl-1,2-oxazol-3-yl)acetamide | Formula: | C6 H8 N2 O2 | SMILES: | c1(C)onc(NC(=O)C)c1 | InChi: | InChI=1S/C6H8N2O2/c1-4-3-6(8-10-4)7-5(2)9/h3H,1-2H3,(H,7,8,9) | Definition date: | 2018-08-13 | Last modified: | 2024-09-27 | Release date: | 2019-12-18 | Identifier: | N-(5-methyl-1,2-oxazol-3-yl)acetamide |
|
| J5J | Name: | N-[(E)-(3-methylphenyl)methylidene]acetamide | Formula: | C10 H11 N O | SMILES: | CC(=O)N=[C@H]c1cc(ccc1)C | InChi: | InChI=1S/C10H11NO/c1-8-4-3-5-10(6-8)7-11-9(2)12/h3-7H,1-2H3/b11-7+ | Definition date: | 2018-08-13 | Last modified: | 2024-09-27 | Release date: | 2019-12-18 | Identifier: | N-[(E)-(3-methylphenyl)methylidene]acetamide |
|
| J5M | Name: | N-{3-[3-(trifluoromethyl)phenyl]prop-2-yn-1-yl}acetamide | Formula: | C12 H10 F3 N O | SMILES: | CC(=O)NCC#Cc1cccc(C(F)(F)F)c1 | InChi: | InChI=1S/C12H10F3NO/c1-9(17)16-7-3-5-10-4-2-6-11(8-10)12(13,14)15/h2,4,6,8H,7H2,1H3,(H,16,17) | Definition date: | 2018-08-13 | Last modified: | 2024-09-27 | Release date: | 2019-12-18 | Identifier: | N-{3-[3-(trifluoromethyl)phenyl]prop-2-yn-1-yl}acetamide |
|
| KE1 | Name: | meropenem, bound form | Formula: | C17 H27 N3 O5 S | SMILES: | C1(C)C(=C(NC1C(C=O)C(C)O)C(O)=O)SC2CNC(C2)C(N(C)C)=O | InChi: | InChI=1S/C17H27N3O5S/c1-8-13(11(7-21)9(2)22)19-14(17(24)25)15(8)26-10-5-12(18-6-10)16(23)20(3)4/h7-13,18-19,22H,5-6H2,1-4H3,(H,24,25)/t8-,9-,10-,11-,12-,13-/m1/s1 | Synonyms: | (4R,5S)-3-{[(3R,5R)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-d
ihydro-1H-pyrrole-2-carboxylic acid | Definition date: | 2018-11-27 | Last modified: | 2024-09-27 | Release date: | 2018-12-19 | Identifier: | (4R,5S)-3-{[(3R,5R)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid |
|
| J5N | Name: | ~{N}-[(2~{S})-1-[(3~{R},3~{a}~{R},6~{R},6~{a}~{R})-6-ethynyl-3-oxidanyl-2,3,3~{a},5,6,6~{a}-hexahydrofuro[3,2-b]pyrrol-4-yl]-4-methyl-1-oxidanylidene-pentan-2-yl]-4-[5-fluoranyl-2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]benzamide | Formula: | C29 H36 F N5 O4 S | SMILES: | CC(C)C[CH](NC(=O)c1ccc(cc1)c2nc(sc2F)N3CCN(C)CC3)C(=O)N4C[CH](C#C)[CH]5OC[CH](O)[CH]45 | InChi: | InChI=1S/C29H36FN5O4S/c1-5-18-15-35(24-22(36)16-39-25(18)24)28(38)21(14-17(2)3)31-27(37)20-8-6-19(7-9-20)23-26(30)40-29(32-23)34-12-10-33(4)11-13-34/h1,6-9,17-18,21-22,24-25,36H,10-16H2,2-4H3,(H,31,37)/t18-,21+,22+,24-,25-/m1/s1 | Definition date: | 2019-02-01 | Last modified: | 2024-09-27 | Release date: | 2020-02-19 | Identifier: | ~{N}-[(2~{S})-1-[(3~{R},3~{a}~{R},6~{R},6~{a}~{R})-6-ethynyl-3-oxidanyl-2,3,3~{a},5,6,6~{a}-hexahydrofuro[3,2-b]pyrrol-4-yl]-4-methyl-1-oxidanylidene-pentan-2-yl]-4-[5-fluoranyl-2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]benzamide |
|
| J5P | Name: | N'-acetyl-2-[(3R)-1,1-dioxo-1lambda~6~-thiolan-3-yl]acetohydrazide | Formula: | C8 H14 N2 O4 S | SMILES: | CC(=O)NNC(=O)CC1CCS(=O)(=O)C1 | InChi: | InChI=1S/C8H14N2O4S/c1-6(11)9-10-8(12)4-7-2-3-15(13,14)5-7/h7H,2-5H2,1H3,(H,9,11)(H,10,12)/t7-/m0/s1 | Definition date: | 2018-08-13 | Last modified: | 2024-09-27 | Release date: | 2019-12-18 | Identifier: | N'-acetyl-2-[(3R)-1,1-dioxo-1lambda~6~-thiolan-3-yl]acetohydrazide |
|
| 0M6 | Name: | N-[(2S)-1,4-dihydroxybutan-2-yl]-N~2~-(phenylcarbamothioyl)-L-leucinamide | Formula: | C17 H27 N3 O3 S | SMILES: | S=C(Nc1ccccc1)NC(C(=O)NC(CCO)CO)CC(C)C | InChi: | InChI=1S/C17H27N3O3S/c1-12(2)10-15(16(23)18-14(11-22)8-9-21)20-17(24)19-13-6-4-3-5-7-13/h3-7,12,14-15,21-22H,8-11H2,1-2H3,(H,18,23)(H2,19,20,24)/t14-,15-/m0/s1 | Synonyms: | SNJ-1715, bound form | Definition date: | 2012-02-28 | Last modified: | 2024-09-27 | Identifier: | N-[(2S)-1,4-dihydroxybutan-2-yl]-N~2~-(phenylcarbamothioyl)-L-leucinamide |
|
| J5S | Name: | N-[(E)-(4-methylphenyl)methylidene]acetamide | Formula: | C10 H11 N O | SMILES: | c1c(C=NC(=O)C)ccc(c1)C | InChi: | InChI=1S/C10H11NO/c1-8-3-5-10(6-4-8)7-11-9(2)12/h3-7H,1-2H3/b11-7+ | Definition date: | 2018-08-13 | Last modified: | 2024-09-27 | Release date: | 2019-12-18 | Identifier: | N-[(E)-(4-methylphenyl)methylidene]acetamide |
|
| J5T | Name: | ~{N}-[(2~{S})-1-[(3~{R},3~{a}~{R},6~{R},6~{a}~{S})-6-chloranyl-3-oxidanyl-2,3,3~{a},5,6,6~{a}-hexahydrofuro[3,2-b]pyrrol-4-yl]-4-methyl-1-oxidanylidene-pentan-2-yl]-4-[5-fluoranyl-2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]benzamide | Formula: | C27 H35 Cl F N5 O4 S | SMILES: | CC(C)C[CH](NC(=O)c1ccc(cc1)c2nc(sc2F)N3CCN(C)CC3)C(=O)N4C[CH](Cl)[CH]5OC[CH](O)[CH]45 | InChi: | InChI=1S/C27H35ClFN5O4S/c1-15(2)12-19(26(37)34-13-18(28)23-22(34)20(35)14-38-23)30-25(36)17-6-4-16(5-7-17)21-24(29)39-27(31-21)33-10-8-32(3)9-11-33/h4-7,15,18-20,22-23,35H,8-14H2,1-3H3,(H,30,36)/t18-,19+,20+,22-,23-/m1/s1 | Definition date: | 2019-02-01 | Last modified: | 2024-09-27 | Release date: | 2020-02-19 | Identifier: | ~{N}-[(2~{S})-1-[(3~{R},3~{a}~{R},6~{R},6~{a}~{S})-6-chloranyl-3-oxidanyl-2,3,3~{a},5,6,6~{a}-hexahydrofuro[3,2-b]pyrrol-4-yl]-4-methyl-1-oxidanylidene-pentan-2-yl]-4-[5-fluoranyl-2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl]benzamide |
|
| J5V | Name: | N-(3-phenylprop-2-yn-1-yl)acetamide | Formula: | C11 H11 N O | SMILES: | C(c1ccccc1)#CCNC(=O)C | InChi: | InChI=1S/C11H11NO/c1-10(13)12-9-5-8-11-6-3-2-4-7-11/h2-4,6-7H,9H2,1H3,(H,12,13) | Definition date: | 2018-08-13 | Last modified: | 2024-09-27 | Release date: | 2019-12-18 | Identifier: | N-(3-phenylprop-2-yn-1-yl)acetamide |
|
| 0MG | Name: | amino{[(4S)-4-amino-5-carboxy-5-oxopentyl]amino}methaniminium | Formula: | C7 H15 N4 O3 | SMILES: | O=C(C(=O)O)C(N)CCCNC(=[NH2+])N | InChi: | InChI=1S/C7H14N4O3/c8-4(5(12)6(13)14)2-1-3-11-7(9)10/h4H,1-3,8H2,(H,13,14)(H4,9,10,11)/p+1/t4-/m0/s1 | Definition date: | 2010-09-24 | Last modified: | 2024-09-27 | Identifier: | amino{[(4S)-4-amino-5-carboxy-5-oxopentyl]amino}methaniminium |
|
| J61 | Name: | N'-acetyl-2-chlorobenzohydrazide | Formula: | C9 H9 Cl N2 O2 | SMILES: | N(C(c1ccccc1Cl)=O)NC(=O)C | InChi: | InChI=1S/C9H9ClN2O2/c1-6(13)11-12-9(14)7-4-2-3-5-8(7)10/h2-5H,1H3,(H,11,13)(H,12,14) | Definition date: | 2018-08-13 | Last modified: | 2024-09-27 | Release date: | 2019-12-18 | Identifier: | N'-acetyl-2-chlorobenzohydrazide |
|
| J64 | Name: | N-[(5-chlorothiophen-2-yl)methyl]acetamide | Formula: | C7 H8 Cl N O S | SMILES: | N(Cc1ccc(Cl)s1)C(C)=O | InChi: | InChI=1S/C7H8ClNOS/c1-5(10)9-4-6-2-3-7(8)11-6/h2-3H,4H2,1H3,(H,9,10) | Definition date: | 2018-08-13 | Last modified: | 2024-09-27 | Release date: | 2019-12-18 | Identifier: | N-[(5-chlorothiophen-2-yl)methyl]acetamide |
|
| KEO | Name: | e(R)-beta-lysyl-hydroxylysine | Formula: | C12 H26 N4 O4 | SMILES: | NCCC[CH](N)CC(=O)NCC[CH](O)C[CH](N)C(O)=O | InChi: | InChI=1S/C12H26N4O4/c13-4-1-2-8(14)6-11(18)16-5-3-9(17)7-10(15)12(19)20/h8-10,17H,1-7,13-15H2,(H,16,18)(H,19,20)/t8-,9-,10-/m0/s1 | Definition date: | 2017-10-05 | Last modified: | 2024-09-27 | Release date: | 2017-11-22 | Identifier: | (2~{S},4~{S})-2-azanyl-6-[[(3~{S})-3,6-bis(azanyl)hexanoyl]amino]-4-oxidanyl-hexanoic acid |
|
| 0MU | Name: | (2R)-5-(acetyloxymethyl)-2-[(1R)-1-[[(5R)-5-azanyl-6-oxidanyl-6-oxidanylidene-hexanoyl]amino]-2-oxidanylidene-ethyl]-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid | Formula: | C16 H23 N3 O8 S | SMILES: | CC(=O)OC[CH]1CS[CH](N=C1C(O)=O)[CH](NC(=O)CCC[CH](N)C(O)=O)C=O | InChi: | InChI=1S/C16H23N3O8S/c1-8(21)27-6-9-7-28-14(19-13(9)16(25)26)11(5-20)18-12(22)4-2-3-10(17)15(23)24/h5,9-11,14H,2-4,6-7,17H2,1H3,(H,18,22)(H,23,24)(H,25,26)/t9-,10+,11+,14+/m0/s1 | Synonyms: | CEPHALOSPORIN C, bound form | Definition date: | 2012-03-05 | Last modified: | 2024-09-27 | Release date: | 2017-07-12 | Identifier: | (2R)-5-(acetyloxymethyl)-2-[(1R)-1-[[(5R)-5-azanyl-6-oxidanyl-6-oxidanylidene-hexanoyl]amino]-2-oxidanylidene-ethyl]-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
| KF2 | Name: | [(1~{R})-1-azanyl-3-phenyl-propyl]-[(2~{S})-2-methanoyl-4-methyl-pentyl]phosphinic acid | Formula: | C16 H26 N O3 P | SMILES: | CC(C)C[CH](C[P](O)(=O)[CH](N)CCc1ccccc1)C=O | InChi: | InChI=1S/C16H26NO3P/c1-13(2)10-15(11-18)12-21(19,20)16(17)9-8-14-6-4-3-5-7-14/h3-7,11,13,15-16H,8-10,12,17H2,1-2H3,(H,19,20)/t15-,16+/m0/s1 | Definition date: | 2019-05-16 | Last modified: | 2024-09-27 | Release date: | 2019-12-18 | Identifier: | [(1~{R})-1-azanyl-3-phenyl-propyl]-[(2~{S})-2-methanoyl-4-methyl-pentyl]phosphinic acid |
|
| 0N3 | Name: | 3-({[(dihydroxyboranyl)methyl]sulfamoyl}methyl)benzoic acid | Formula: | C9 H12 B N O6 S | SMILES: | O=S(=O)(NCB(O)O)Cc1cccc(c1)C(=O)O | InChi: | InChI=1S/C9H12BNO6S/c12-9(13)8-3-1-2-7(4-8)5-18(16,17)11-6-10(14)15/h1-4,11,14-15H,5-6H2,(H,12,13) | Definition date: | 2012-03-13 | Last modified: | 2024-09-27 | Release date: | 2012-09-21 | Identifier: | 3-({[(dihydroxyboranyl)methyl]sulfamoyl}methyl)benzoic acid |
|
| 0N4 | Name: | [({[4-(1H-tetrazol-5-yl)phenyl]sulfonyl}amino)methyl]boronic acid | Formula: | C8 H10 B N5 O4 S | SMILES: | O=S(=O)(c2ccc(c1nnnn1)cc2)NCB(O)O | InChi: | InChI=1S/C8H10BN5O4S/c15-9(16)5-10-19(17,18)7-3-1-6(2-4-7)8-11-13-14-12-8/h1-4,10,15-16H,5H2,(H,11,12,13,14) | Definition date: | 2012-03-13 | Last modified: | 2024-09-27 | Release date: | 2012-09-21 | Identifier: | [({[4-(1H-tetrazol-5-yl)phenyl]sulfonyl}amino)methyl]boronic acid |
|
| J6S | Name: | (3E,5E)-6-(4-nitrophenyl)-2-oxohexa-3,5-dienoic acid | Formula: | C12 H9 N O5 | SMILES: | C(C([C@H]=CC=Cc1ccc([N+](=O)[O-])cc1)=O)(O)=O | InChi: | InChI=1S/C12H9NO5/c14-11(12(15)16)4-2-1-3-9-5-7-10(8-6-9)13(17)18/h1-8H,(H,15,16)/b3-1+,4-2+ | Synonyms: | 4-nitro-cinnamylidenepyruvate, bound form | Definition date: | 2018-08-15 | Last modified: | 2024-09-27 | Release date: | 2019-08-14 | Identifier: | (3E,5E)-6-(4-nitrophenyl)-2-oxohexa-3,5-dienoic acid |
|
| 0NA | Name: | [({[6-(1H-tetrazol-5-yl)pyridin-3-yl]sulfonyl}amino)methyl]boronic acid | Formula: | C7 H9 B N6 O4 S | SMILES: | O=S(=O)(c2cnc(c1nnnn1)cc2)NCB(O)O | InChi: | InChI=1S/C7H9BN6O4S/c15-8(16)4-10-19(17,18)5-1-2-6(9-3-5)7-11-13-14-12-7/h1-3,10,15-16H,4H2,(H,11,12,13,14) | Definition date: | 2012-03-16 | Last modified: | 2024-09-27 | Release date: | 2012-09-21 | Identifier: | [({[6-(1H-tetrazol-5-yl)pyridin-3-yl]sulfonyl}amino)methyl]boronic acid |
|
| KFB | Name: | 5-Aminovaleric Acid | Formula: | C5 H11 N O2 | SMILES: | NCCCCC(O)=O | InChi: | InChI=1S/C5H11NO2/c6-4-2-1-3-5(7)8/h1-4,6H2,(H,7,8) | Synonyms: | 5-aminopentanoic acid | Definition date: | 2019-05-17 | Last modified: | 2024-09-27 | Release date: | 2019-10-23 | Identifier: | 5-azanylpentanoic acid |
|
| J6Z | Name: | (2R)-butane-2-sulfonate | Formula: | C4 H9 O3 S | SMILES: | [O-]S(=O)(=O)C(C)CC | InChi: | InChI=1S/C4H10O3S/c1-3-4(2)8(5,6)7/h4H,3H2,1-2H3,(H,5,6,7)/p-1/t4-/m1/s1 | Definition date: | 2009-07-23 | Last modified: | 2024-09-27 | Identifier: | (2R)-butane-2-sulfonate |
|
| 0NB | Name: | [({[3-chloro-4-(1H-tetrazol-5-yl)phenyl]sulfonyl}amino)methyl]boronic acid | Formula: | C8 H9 B Cl N5 O4 S | SMILES: | O=S(=O)(c2cc(Cl)c(c1nnnn1)cc2)NCB(O)O | InChi: | InChI=1S/C8H9BClN5O4S/c10-7-3-5(20(18,19)11-4-9(16)17)1-2-6(7)8-12-14-15-13-8/h1-3,11,16-17H,4H2,(H,12,13,14,15) | Definition date: | 2012-03-16 | Last modified: | 2024-09-27 | Release date: | 2012-09-21 | Identifier: | [({[3-chloro-4-(1H-tetrazol-5-yl)phenyl]sulfonyl}amino)methyl]boronic acid |
|